Abstract
Background
Glottal insufficiency, mostly caused by unilateral vocal fold paralysis (UVFP) or vocal fold atrophy can be treated by injection laryngoplasty (IL). Materials such as hyaluronic acid (HA) gels are now widely available and used to improve voice quality. Various durability and effects of HA injection laryngoplasties have been reported. The aim of this study is to provide a systematic review of the literature for the use of HA in injection laryngoplasties.
Methods
A systematic literature search was conducted in PubMed and Cochrane Libraries. Three reviewers assessed original research studies concerning vocal fold augmentation with HA for eligibility. English written full-text human studies from 2000 to 2020 with EBM level 1b—2 were included. In vitro studies, animal studies, case reports, case–control studies, correspondence and review articles, and articles with other injection materials were excluded. Demographical data, indication, type of HA, evaluation methods, follow-up, durability of implanted material and complications were assessed.
Results
A total number of 311 articles were found in PubMed and Cochrane Library, 13 studies were eligible for final analysis with 1063 patients, mean age of patients was 58.7 years. Main indication for HA IL was unilateral vocal fold paralysis, evaluation methods were subjective—VHI (Voice Handicap Index) questionnaire and objective—acoustic and aerodynamic measurements, mean time of follow-up was 5.9 months. Large-particle HA gels were more favorable for longer durability than small-particle HA, reported time of resorption of HA gels ranges between 6 and 12 months, and complication rate was low.
Conclusion
Hyaluronic acid injection laryngoplasty increases voice quality, improves results of voice therapy, and can be recommended as overlap treatment before permanent medialization surgery. Compared to other injected materials, HA seems to have more favorable effect on vibratory functions of the vocal folds and thus on the voice quality parameters.
Similar content being viewed by others
References
Wang C-C, Wu S-H, Tu Y-K, Lin W-J, Liu S-A (2020) Hyaluronic acid injection laryngoplasty for unilateral vocal fold paralysis-a systematic review and meta-analysis. Cells 9:E2417. https://doi.org/10.3390/cells9112417
Gaston J, Thibeault SL (2013) Hyaluronic acid hydrogels for vocal fold wound healing. Biomatter 3:e23799. https://doi.org/10.4161/biom.23799
Elibol E, Yılmaz YF, Ünal A, Ozcan M, Kum NY, Kum RO, Kulaçoğlu S (2021) Effects of hyaluronic acid-collagen nanofibers on early wound healing in vocal cord trauma. Eur Arch Otorhinolaryngol 278:1537–1544. https://doi.org/10.1007/s00405-021-06703-x
Holm A, Hellman U, Laurent C, Laurell G, Nylander K, Olofsson K (2018) Hyaluronan in vocal folds and false vocal folds in patients with recurrent respiratory papillomatosis. Acta Otolaryngol 138:1020–1027. https://doi.org/10.1080/00016489.2018.1500712
Jeong G-E, Lee DH, Lee YS, Ahn DS, Lee DK, Choi S-H, Nam SY, Kim SY (2020) Treatment efficacy of voice therapy following injection laryngoplasty for unilateral vocal fold paralysis. J Voice S0892–1997(20):30188. https://doi.org/10.1016/j.jvoice.2020.05.014
Oxford Centre for Evidence-Based Medicine: Levels of Evidence (March 2009) — Centre for Evidence-Based Medicine (CEBM), University of Oxford. https://www.cebm.ox.ac.uk/resources/levels-of-evidence/oxford-centre-for-evidence-based-medicine-levels-of-evidence-march-2009. Accessed 13 Feb 2022
Lau DP, Lee GA, Wong SM, Lim VP, Chan YH, Tan NG, Rammage LA, Morrison MD (2010) Injection laryngoplasty with hyaluronic acid for unilateral vocal cord paralysis. randomized controlled trial comparing two different particle sizes. J Voice 24:113–118. https://doi.org/10.1016/j.jvoice.2008.05.007
Hertegård S, Hallén L, Laurent C, Lindström E, Olofsson K, Testad P, Dahlqvist A (2002) Cross-linked hyaluronan used as augmentation substance for treatment of glottal insufficiency: safety aspects and vocal fold function. Laryngoscope 112:2211–2219. https://doi.org/10.1097/00005537-200212000-00016
Enver N, Azizli E, Akbulut S, Çadallı Tatar E, Yelken MK, Öztürk K, Coşkun H, Birkent AH, Büyükatalay ZÇ, Özgürsoy OB et al (2021) Inflammatory complications of vocal fold injection with hyaluronic acid: a multiinstitutional study. Turk J Med Sci 51:819–825. https://doi.org/10.3906/sag-2008-5
Reiter R, Rudolf R, Brosch S, Sibylle B (2012) Laryngoplasty with hyaluronic acid in patients with unilateral vocal fold paralysis. J Voice 26:785–791. https://doi.org/10.1016/j.jvoice.2011.11.007
Szkiełkowska A, Miaśkiewicz B, Remacle M, Krasnodębska P, Skarżyński H (2013) Quality of the voice after injection of hyaluronic acid into the vocal fold. Med Sci Monit 19:276–282. https://doi.org/10.12659/MSM.883888
Upton DC, Johnson M, Zelazny SK, Dailey SH (2013) Prospective evaluation of office-based injection laryngoplasty with hyaluronic acid gel. Ann Otol Rhinol Laryngol 122:541–546. https://doi.org/10.1177/000348941312200901
Halderman AA, Bryson PC, Benninger MS, Chota R (2014) Safety and length of benefit of restylane for office-based injection medialization-a retrospective review of one institution’s experience. J Voice 28:631–635. https://doi.org/10.1016/j.jvoice.2014.01.010
Verma SP, Dailey SH (2014) Office-based injection laryngoplasty for the management of unilateral vocal fold paralysis. J Voice 28:382–386. https://doi.org/10.1016/j.jvoice.2013.10.006
Kim G-H, Lee J-S, Lee C-Y, Lee Y-W, Bae I-H, Park H-J, Lee B-J, Kwon S-B (2018) Effects of injection laryngoplasty with hyaluronic acid in patients with vocal fold paralysis. Osong Public Health Res Perspect 9:354–361. https://doi.org/10.24171/j.phrp.2018.9.6.10
Pei Y-C, Chuang H-F, Chang C-F, Chang T-L, Chiang H-C, Fang T-J (2018) Voice range change after injection laryngoplasty for unilateral vocal fold paralysis. J Voice 32:625–632. https://doi.org/10.1016/j.jvoice.2017.07.019
van den Broek EMJM, Heijnen BJ, Hendriksma M, Langeveld APM, van Benthem PPG, Sjögren EV (2019) Bilateral trial vocal fold injection with hyaluronic acid in patients with vocal fold atrophy with or without sulcus. Eur Arch Otorhinolaryngol 276:1413–1422. https://doi.org/10.1007/s00405-019-05347-2
Bertroche JT, Radder M, Kallogjeri D, Paniello RC, Bradley JP (2019) Patient-defined duration of benefit from juvederm (Hyaluronic Acid) used in injection laryngoplasty. Laryngoscope 129:2744–2747. https://doi.org/10.1002/lary.27842
Trautman J, Sarofim M, Kwok A, Creber N, Winn R (2020) Isolated unilateral vocal fold palsy: a rare complication of base of skull trauma. ANZ J Surg 90:171–173. https://doi.org/10.1111/ans.15043
SeyedToutounchi SJ, Eydi M, Golzari SE, Ghaffari MR, Parvizian N (2014) Vocal cord paralysis and its etiologies: a prospective study. J Cardiovasc Thorac Res 6:47–50. https://doi.org/10.5681/jcvtr.2014.009
Lee Y-C, Pei Y-C, Lu Y-A, Chung H-F, Li H-Y, Lee L-A, Fang T-J (2021) Long-lasting effect after single hyaluronate injection for unilateral vocal fold paralysis: does concentration matter? Biomolecules 11:1580. https://doi.org/10.3390/biom11111580
Litts JK, Fink DS, Clary MS (2018) The effect of vocal fold augmentation on cough symptoms in the presence of glottic insufficiency. Laryngoscope 128:1316–1319. https://doi.org/10.1002/lary.26914
Dominguez LM, Tibbetts KM, Simpson CB (2017) Inflammatory reaction to hyaluronic acid: a newly described complication in vocal fold augmentation. Laryngoscope 127:445–449. https://doi.org/10.1002/lary.26156
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All the authors declare that they have no conflict of interest that may have influenced either the conduct or the presentation of the research.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Švejdová, A., Dršata, J., Mejzlík, J. et al. Injection laryngoplasty with hyaluronic acid for glottal insufficiency in unilateral vocal fold paralysis: a systematic review of the literature. Eur Arch Otorhinolaryngol 279, 5071–5079 (2022). https://doi.org/10.1007/s00405-022-07437-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-022-07437-0